AUVEN THERAPEUTICS: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to AUVEN THERAPEUTICS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 121 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-10 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 122 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 123 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 124 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-11-02 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 125 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 126 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | HMPC00495028 | 2024-10-16 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 127 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-23 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 128 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-07-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875029 · amendedFEC filing ↗ |
| 129 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-18 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 130 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-12 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 131 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-10 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 132 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 133 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 134 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-20 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 135 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-15 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 136 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-10 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 137 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 138 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-09 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 139 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 140 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-18 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.